[1]
“Lynparzatm (olaparib): new medicine for targeted therapy of ovarian cancer”, Onkologija, vol. 20, no. 1, pp. 12–14, Jun. 2016, Accessed: Sep. 03, 2026. Available: https://www.revijaonkologija.si/Onkologija/article/view/60